Shows
DCAT Value Chain Insights’ Production to PrescriptionGlobal API Outlook: Will Supply Lines Change Amid Tariff Uncertainty?As evolving US trade policy looms, what are the demand–supply fundamentals now in the global market for active pharmaceutical ingredients (APIs)? A look at the demand side—size, growth rates, and trends— and the supply side—key segments for global API manufacturing and its geographic dispersion. Plus, examining the impact of potential tariffs on manufacturing and supply chains. Support the show2025-05-0816 minDCAT Value Chain Insights’ Production to PrescriptionBiomanufacturing: How are Industry Capacity & Supply Chains Trending?What is industry capacity utilization for biomanufacturing among the major systems/platforms (mammalian, microbial, and advanced therapies, and is there too much capacity or is the market tight? Is biomanufacturing outsourcing up or down? Are biopharma companies outsourcing more or less? Plus the impact on evolving trade policy on biomanufacturing supply chains. Featuring: Eric Langer, MBA, Managing Partner & President, BioPlan Associates and Renaud Jacquemart, PhD, MBA, Senior Advisor, BioPlan AssociatesSupport the show2025-04-0338 minDCAT Value Chain Insights’ Production to PrescriptionParenteral Drug Mfg—CDMO Outlook: a Capacity Crunch of Easing?How are supply and demand shaping up for sterile manufacturing and aseptic fill–finish in the CDMO/CMO sector? Is a capacity crunch or capacity ease in the making? And how will hot-product areas, such as GLP-1 agonist impact market fundamentals. Featuring Ian Tzeng, Managing Director and Partner, L.E.K. Consulting, where he focuses on healthcare and life sciences, including pharmaceuticals, vaccines, and leads L.E.K.’s Pharmaceutical Contract Services practice. Support the show2025-02-0627 minDCAT Value Chain Insights’ Production to PrescriptionBio/Pharma Industry Outlook, Supply Chains 2025: The Year AheadWhat will be the key issues shaping bio/pharma supply chains in 2025? Looking at the impact of potential changes in US tariff and trade policy. Plus, what lies ahead in product-specific supply chains for sterile injectables and antibody drug conjugates. And the latest on how companies are advancing upstream supplier risk monitoring and predictive risk planning, including through digitalization and AI. Featuring: Derron Stark, EY-Parthenon Partner, Strategy & Transactions – Health Sciences & Wellness, Supply Chain, Ernst & Young LLPSupport the show2024-12-3024 min
Comerit "What's Up Enterprise?" PodcastEpisode 21 - You Won't Believe How This Famous Music Producer is Using AIThis week's episode is a mind-blowing interview with Dwane ("DCat") Cornelius, the CEO of DCat Music Company and Just A Minute Music Library, a music publisher, platinum engineer, producer, musician, and entrepreneur! DCat's musical journey is nothing short of legendary. He's toured with iconic artists like Earth, Wind & Fire and Natalie Cole, produced tracks for Snoop Dogg, and collaborated with the legendary George Clinton. 🔥 Watch now to hear DCat share:The music industry's untold technological challenges and opportunitiesDCat's groundbreaking crypto project, Soul JamThe power of AI an...2024-06-0645 minDCAT Value Chain Insights’ Production to PrescriptionWhat’s Trending: Parenteral Drug Development & ManufacturingWhat are some key trends and issues arising in parenteral drug development and manufacturing? From more complex molecules and modalities and sterile drug-product capacity market shifts, DCAT Value Chain Insights takes an inside look. For the text version of this article visit dcatvci.org.Key topics: (see Chapter Markers in drop down menu in audio player above) Major trends in parenteral drug development Long peptides in NDAs and BLAs New complex modalities Sterile drug-product capacity market shifts Complex sterile injectables Regulatory issues Digitalization and automation Podcast Sponsor: Vetter Pharma I...2024-02-2216 minDCAT Value Chain Insights’ Production to PrescriptionCDMOs/CMOs: The Movers and Shakers of 2023As 2023 comes to a close, what were the largest mergers and acquisitions and expansions made by CDMOs/CMOs in 2023? DCAT Value Chain Insights looks at which companies topped the headlines this year and the leading moves they made. For the text version of this article visit dcatvci.org.Key topics: (see Chapter Markers in drop down menu in audio player above) BaxterSamsung BiologicsLotte BiologicsFujifilm Diosynth BiotechnologiesLonza CambrexExpansions in peptides, oligonucleotides BachemAgilent TechnologiesWuXi STACordenPharmaAjinomotoBain’s acquisition of F.I.S.eureKINGNew CDMOs enter the market Bridgewest Group SynCrest NewBiologix Ascend Gene & Cell Therapies Podca...2023-12-2127 minDCAT Value Chain Insights’ Production to PrescriptionCDMO/CMO Mid-Year Review: Tracking the Key Moves Thus Far in 2023As we near the mid-year mark, what have been the key moves—mergers and acquisitions, expansions, and new CDMOs entering the market—thus far in 2023? DCAT Value Chain Insights takes an inside look on what is on the industry’s radar. For the text version of this article visit dcatvci.org. Key topics: (see Chapter Markers in drop down menu in audio player above) BaxterLarge-scale biomanufacturing expansions continue Samsung BiologicsLotte BiologicsFujifilm Diosynth BiotechnologiesLonza WuXi BiologicsExpansions in Peptides and Oligonucleotides Ramp UpBachemAgilent TechnologiesWuXi STACordenPharmaNew CDMOs Enter the Market eureKINGNewBiologixAscend Gene & Cell TherapiesPodcast...2023-06-1423 minDCAT Value Chain Insights’ Production to PrescriptionAPI Alert: EU Proposes New Requirements To Secure Pharma Supply ChainsThe European Commission has issued its long-awaited proposal to reform pharmaceutical legislation in the EU, the first major overhaul in 20 years, which includes new requirements to address drug shortages and secure supply chains. For the text version of this article visit dcatvci.org.Key topics: (see Chapter Markers in drop down menu in audio player above) Proposed reforms Security of supply and supply-chain reforms Specific proposals Podcast Sponsor: BIOVECTRALinks: Subscribe to our e-newsletter at www.dcatvci.org Follow us on Twitter @DCATvci ...2023-05-0213 min
House Radio EcuadorHouse Radio Ecuador #63 - Dcat Guest MixDisfruta y comparte.
Sigue a Dcat
https://www.facebook.com/dj.dcat
https://www.instagram.com/dcaaaaat/
Tracklist
0:00 : Faithless - We Come One (Gentech Remix)
2:45 : Push - Strange world (Joyhauser Remix)
5:56 : Karney – Smiler (Nineteen Sines Remix)
10:00 : The Weeknd - Blinding Lights (Mark Sherry Remix)
14:55 : Mark Dekoda - Rave Harder Techno Bass
17:52 : Monika Kruse - Latin Lovers (Greg Downey Rework)
19:56 : Technotronic - Pump Up the Jam (Mark Sherry Remix)
22:58 : Kate Bush - Running Up That Hill (Mark Sherry Remix)2023-02-1028 minDCAT Value Chain Insights’ Production to PrescriptionThe CDMO/CMO Report: Parenteral DrugsIncreased demand in biologic-based drug development is a key factor driving demand for parenteral drug manufacturing. What are key trends and expansions by CDMO/CMOs in parenteral drug manufacturing? DCAT Value Chain Insights rounds up the latest developments among CDMO/CMOs. For the text version of this article visit dcatvci.org. Key topics: (see Chapter Markers in drop down menu in audio player above) Recent expansion projects Baxter BioPharma Solutions Vetter Recipharm WuXi STA Jubilant HollisterStier PCI Pharma Services Grand River Aseptic Manufacturing Catalent Thermo Fisher Scientific Lonza Carbogen Amcis Alcami Delpharm Fareva WuXi Biol...2022-11-1630 minDCAT Value Chain Insights’ Production to PrescriptionDrug Products: Key Trends & Recent ApprovalsWhat are noteworthy trends in drug delivery and drug-product development in key dosage forms: solid dosage and parenteral drugs? A look at key technology advances and recent new drug approvals. For the text version of this article visit dcatvci.org.Key topics: (see Chapter Markers in drop down menu in audio player above)Recent trends: new drug approvalsTechnology advancesEnable Injections’ on-body subcutaneous drug-delivery systemLilly’s and Triastek’s pact for 3-D printing for oral drug deliveryMultifunctional wireless robots in drug deliveryAdvances in implantable devices for drug delivery Sponsor: Vetter Pharma Interna...2022-08-1711 minDCAT Value Chain Insights’ Production to PrescriptionCDMOs/CMOs Expand High-Potency API ManufacturingGrowth in the oncology drug market continues to spur demand for high-potency API manufacturing. Which CDMOs/CMOs are expanding? DCAT Value Chain Insights rounds up the latest investments. For the text version of this article visit dcatvci.org.Key topics: (see Chapter Markers in drop down menu in audio player above)A roundup of recent investments in HPAPI manufacturing WuXi STA MilliporeSigmaPiramal Pharma SolutionsCambrexHAS Healthcare Advanced SynthesisAGC Fine ChemicalsLonzaCarbogen AmcisSterling Pharma SolutionsAjinomoto Bio-Pharma ServicesNovasepOlonCerbios-PharmaFormosa LaboratoriesSai Life SciencesBSP PharmaceuticalsSeqensCordenPharma Sponsor: BIOVECTRA Links:Subs...2022-07-1421 min
Molecule to Market: Inside the outsourcing spaceDiaries of DCATLast week marked the return of DCAT in New York City. A prestigious event that’s open to companies engaged in the Biotech and Pharmaceutical manufacturing space…
With the massive return this year of events. Your host, Raman Sehgal, decided to shake things up this year and do things differently, taking your favourite life science podcast Molecule to market with him… Equipped with only a laptop and a microphone, he hit the event space in style and interviewed some great guests along the way.
Listen to a variety of select guests at the top of their...2022-04-0628 minMolecule to Market: Inside the outsourcing spaceDiaries of DCAT
Last week marked the return of DCAT in New York City. A prestigious event that's open to companies engaged in the Biotech and Pharmaceutical manufacturing space...
With the massive return this year of events. Your host, Raman Sehgal, decided to shake things up this year and do things differently, taking your favourite life science podcast Molecule to market with him… Equipped with only a laptop and a microphone, he hit the event space in style and interviewed some great guests along the way.
Listen to a variety of select guest...2022-04-0425 minDCAT Value Chain Insights’ Production to PrescriptionIncorporating Sustainability into the Bio/Pharma Supply Chain: Where Does the Industry Stand?A newly released DCAT benchmarking study examines the targets and progress made by bio/pharma companies and suppliers in reaching their sustainability goals. For the text version of this article visit dcatvci.org.Key topics: (see Chapter Markers in drop down menu in audio player above)Sustainability and the bio/pharma supply chainKey finding: External stakeholders drive effortsKey finding: Supply-chain sustainability lags internal effortsKey finding: Measuring achievement a major challengeKey finding: Factoring sustainability into purchasing decisions Concluding thoughtsSponsor: LGM PharmaLinks:...2022-03-3115 min